This event is hybrid - join in person or online.
The lecture is entitled ‘From Aston Research Laboratories to Aston Particle Technologies – Developing Medicines for Children’. Professor Mohammed began his academic career developing drug formulations suitable for children, initially working in his own discipline, before moving to a multidisciplinary team comprising experts in engineering, pharmacology, clinical and pharmacy practice, pharmacokinetics and cell biology.
Developing medicines suitable for children is more complex than for adults. To create a medicine, the active pharmaceutical ingredient (API), or drug, is blended with a carrier, known as an excipient. For children, there are fewer safe excipients available, with the added challenge of producing a medicine with a high enough API loading and an acceptable taste.
Professor Chris Langley, Acting Executive Dean and Pro-Vice-Chancellor of the College of Health and Life Sciences said:
“This inaugural lecture promises to provide a fascinating insight into the importance of Afzal’s work within pharmacy. As one of the country’s leading pharmaceutical scientists, this is an opportunity to gain a real understanding of how Afzal has contributed to the development of drug formulation and in turn, benefited countless patients around the globe.”
